Cited by 49Neuroendocrine regulation and behaviorReceptor Mechanisms and SignalingNeuropeptides and Animal Physiology

A ghrelin receptor and oxytocin receptor heterocomplex impairs oxytocin mediated signalling

Wallace Fitzsimons, Shauna E., Chruścicka, Barbara, Druelle, Clementine, Stamou, Panagiota, Nally, Ken, Dinan, Timothy G., Cryan, John F., Schellekens, Harriët·2019·Neuropharmacology

Abstract

Oxytocin mediates its behavioural effects via the centrally expressed oxytocin receptor (OTR). Oxytocin signalling has been implicated in multiple disorders involving centrally regulated pathways, including obesity, autism, schizophrenia and depression. The OTR has been described to have a complex downstream signalling pathway and an increased understanding of oxytocinergic signalling is needed for the development of novel and better treatments for centrally regulated disorders. The ghrelin receptor (GHSR), known primarily for its role in centrally regulated energy balance and food intake, has in more recent years also been shown to play a role in mood disorders, including anxiety and depression. Although there have been suggestions of crosstalk between both signalling systems, these have largely been unexplored to date. Here we show, to our knowledge for the first-time, compelling evidence for the formation of an OTR and GHSR heterocomplex, resulting in significant modulation of OTR downstream signalling. Co-localized expression of the OTR and GHSR is shown in a heterologous cellular expression system and in primary cultures of the hypothalamus and hippocampus. A physical interaction between the OTR and GHSR is confirmed using flow-cytometry based fluorescence resonance energy transfer (fcFRET). Interestingly, co-expression of the GHSR results in a significant attenuation of OTR-mediated Gαq signalling and changes in receptor trafficking within the cell. Together, these data demonstrate a potential functional relevance of an OTR/GHSR heterocomplex and its ability to alter OTR signalling, which is poised to have important implications for future therapeutic strategies, involving oxytocinergic signalling. This article is part of the Special Issue entitled 'Receptor heteromers and their allosteric receptor-receptor interactions'.

Integrity signals

Registry

Crossref · 10.1016/j.neuropharm.2018.12.022

Cites

119 of 119 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 120 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Wallace Fitzsimons, S. E., Chruścicka, B., Druelle, C., Stamou, P., Nally, K., Dinan, T. G., Cryan, J. F., & Schellekens, H.
Affiliations
University College Cork (IE)
Corresponding author
Schellekens, Harriët
Venue
Neuropharmacology
Publisher
Elsevier BV
Published
2019-07
Volume
152
Pages
90-101
ISSN
0028-3908 (ISSN-L)
OpenAlex
W2905716623
Cited by
49
References
120
Citations by year
2025: 4 · 2024: 7 · 2023: 1 · 2022: 9 · 2021: 18 · 2020: 4 · 2019: 6
FWCI
9.50
Type
journal article
Language
en
Open access
closed
Locations
  • Neuropharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Science Foundation Ireland Research Centre (SFI/12/RC/2273)
  • APC Microbiome Institute Ireland
Topics
  • Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords
oxytocin receptor, growth hormone secretagogue receptor, receptor heteromers, receptor trafficking, hypothalamus, hippocampus, receptor cross-talk, depression, anxiety, mood disorders
MeSH terms
Humans, Oxytocin, Protein Binding, Receptors, Oxytocin, Receptor Cross-Talk, Ghrelin, Receptors, Ghrelin, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review